Diabetes

Screengrab of the Wellthy Therapeutics website.

By Dean Koh June 12, 2019
At the 79th Annual Scientific Sessions of the American Diabetes Association in San Francisco, pharma giant Roche and India-based digital therapeutics company Wellthy Therapeutics presented real world data of improved diabetes care outcomes in a South Asian population when patients followed prescribed plan of medication and lifestyle modification in conjunction with a combination therapy of self-...
By Dave Muoio May 28, 2019
Aggregated real-world outcome data collected from thousands of Medtronic MiniMed 670G users indicate that patients on the system spend an average 71% of their time within an optimal glycemic range. Collected from nearly 8 million days of recorded system use and announced by Medtronic today in a press release, the new findings also suggest that this rate increased further for those who employed...
By Leontina Postelnicu May 23, 2019
Innovation and tech company Satellite Applications Catapult and the NHS Arden and Greater East Midlands Commissioning Support Unit (CSU) announced this week that they have agreed a formal partnership that looks at leveraging the potential of satellite technology in the digital transformation of healthcare. Oxfordshire-based Satellite Applications Catapult, which was established by Innovate UK in...
By Dave Muoio May 20, 2019
On Friday, the FDA issued a warning to patients and providers describing the dangers of diabetes management devices and software that haven’t been assessed by the agency. These include any unapproved or unauthorized continuous glucose monitors, insulin pumps and automated insulin dosing systems, whether used as a standalone device or integrated as part of a glucose management system. “These...
By Dave Muoio May 13, 2019
Somerville, Massachusetts-based Podimetrics, maker of a connected device for diabetic foot ulcer detection, has raised $13.4 million in Series B funding. Rock Health, Norwich Ventures and Scientific Health Development each participated in the round. WHAT THEY DO Podimetrics’ platform consists of a cellular-connected SmartMat for use in the home, and a corresponding clinician-facing dashboard....
By Jonah Comstock May 9, 2019
Working with pharma giant Eli Lilly and Company, chronic disease management company Livongo has completed a retrospective analysis of more than 10,000 paitents, which suggests that Livongo's diabetes program can prevent $88 worth of medical spending per person per month.  Citing an average cost to employers of $68 per person per month, including about $30 worth of diabetes management products,...
By Dave Muoio April 30, 2019
The Centers for Medicare and Medicare Services has recognized chronic disease management company Livongo as an enrolled provider for Medicare Advantage members, the startup announced this morning in a release. And, to kick off its new designation, Livongo’s diabetes management offering will be available this June to Medicare Advantage members receiving care through a Cambia Health Solution...
By Tammy Lovell April 16, 2019
When Siddharth Sharma received a diagnosis of type 1 diabetes, his first reaction was to create a spreadsheet of health data. “As an engineer, I did the most logical thing when I came back from the doctor with my insulin and my needles; I got out my laptop and opened a spreadsheet. I started logging everything to find out what was going on,” he tells MobiHealthNews. However, Sharma knows that not...

Photo credit: Biolinq

By Laura Lovett March 28, 2019
This morning Biolinq, a digital health company specializing in minimally invasive continuous glucose monitoring, raised $4.75 million in extended Series A financing. This new capital was led by JDRF T1D Fund, Aphelion Capital and LifeSci Venture Partners.  This latest funding announcement will build on the $10 million the company raised in November of 2017, bringing the total Series A capital to...
By Laura Lovett March 25, 2019
On Friday, Senseonics, maker of the implantable continuous glucose monitoring system Eversense, announced a new program geared towards patients with high-deductible insurance plans or plans that don’t cover the full cost of the CGM.  The new program, called Eversense Bridge, charges patients $99 for the Eversense CGM system, in addition to the cost of the sensor placement by their provider....